Literature DB >> 17242490

The role of IL-6 in mediating the anti-inflammatory effects of exercise.

A M W Petersen1, B K Pedersen.   

Abstract

Regular exercise offers protection against all cause mortality and there is evidence from randomised intervention studies that physical training is effective as a treatment in patients with chronic heart diseases, type 2 diabetes and symptoms related to the metabolic syndrome. Chronic diseases such as cardiovascular disease, type 2 diabetes and cancer are associated with chronic low-grade systemic inflammation. It has been demonstrated that regular exercise induces anti-inflammatory effects with elevated levels of anti-inflammatory cytokines and suppression of TNF-alpha production. Thereby, exercise offers protection against TNF-alpha-induced insulin resistance. Otherwise, the exercise-induced production and release of IL-6 from myofibers may contribute to abrogate an atherogenic lipid profile, which is often associated with chronic diseases. This review focuses on the anti-inflammatory effects of exercise and how this may contribute to mediate the beneficial health effects of exercise training in patients with chronic diseases associated with chronic low-grade inflammation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17242490

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  102 in total

1.  Exercise, sleep quality, and mediators of sleep in breast and prostate cancer patients receiving radiation therapy.

Authors:  Lisa K Sprod; Oxana G Palesh; Michelle C Janelsins; Luke J Peppone; Charles E Heckler; M Jacob Adams; Gary R Morrow; Karen M Mustian
Journal:  Community Oncol       Date:  2010-10

2.  Exercise, inflammation and aging.

Authors:  Jeffrey A Woods; Kenneth R Wilund; Stephen A Martin; Brandon M Kistler
Journal:  Aging Dis       Date:  2011-10-29       Impact factor: 6.745

3.  Immune responses to low back pain risk factors.

Authors:  Riley E Splittstoesser; William S Marras; Thomas M Best
Journal:  Work       Date:  2012

4.  Voluntary exercise together with oral caffeine markedly stimulates UVB light-induced apoptosis and decreases tissue fat in SKH-1 mice.

Authors:  Yao-Ping Lu; Bonnie Nolan; You-Rong Lou; Qing-Yun Peng; George C Wagner; Allan H Conney
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-30       Impact factor: 11.205

Review 5.  Molecular inflammation: underpinnings of aging and age-related diseases.

Authors:  Hae Young Chung; Matteo Cesari; Stephen Anton; Emanuele Marzetti; Silvia Giovannini; Arnold Young Seo; Christy Carter; Byung Pal Yu; Christiaan Leeuwenburgh
Journal:  Ageing Res Rev       Date:  2008-07-18       Impact factor: 10.895

6.  The importance of the cellular stress response in the pathogenesis and treatment of type 2 diabetes.

Authors:  Philip L Hooper; Gabor Balogh; Eric Rivas; Kylie Kavanagh; Laszlo Vigh
Journal:  Cell Stress Chaperones       Date:  2014-02-13       Impact factor: 3.667

7.  Biobehavioral factors mediate exercise effects on fatigue in breast cancer survivors.

Authors:  Laura Q Rogers; Sandra Vicari; Rita Trammell; Patricia Hopkins-Price; Amanda Fogleman; Allison Spenner; Krishna Rao; Kerry S Courneya; Karen S Hoelzer; Randall Robbs; Steven Verhulst
Journal:  Med Sci Sports Exerc       Date:  2014-06       Impact factor: 5.411

8.  Sleep loss activates cellular inflammatory signaling.

Authors:  Michael R Irwin; Minge Wang; Denise Ribeiro; Hyong Jin Cho; Richard Olmstead; Elizabeth Crabb Breen; Otoniel Martinez-Maza; Steve Cole
Journal:  Biol Psychiatry       Date:  2008-06-17       Impact factor: 13.382

9.  Human IL6 enhances leptin action in mice.

Authors:  M Sadagurski; L Norquay; J Farhang; K D'Aquino; K Copps; M F White
Journal:  Diabetologia       Date:  2009-11-10       Impact factor: 10.122

10.  Aerobic exercises alleviate symptoms of fatigue related to inflammatory cytokines in obese patients with type 2 diabetes.

Authors:  Shehab M Abd El-Kader; Osama H Al-Jiffri; Fadwa M Al-Shreef
Journal:  Afr Health Sci       Date:  2015-12       Impact factor: 0.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.